Multiple Myeloma is a type of blood cancer. This study tests a new treatment called BMS-986393, which is a CAR T Cell Therapy. CAR T cells are special cells made in a lab that help your body fight cancer. This treatment is for people whose myeloma has come back or didn't get better after other treatments. You can join this study if you have tried different myeloma treatments before but still have the disease. Doctors will check your health and the myeloma's progress to see if you qualify. However, you can't join if you have brain involvement with myeloma or certain infections. This study will check if BMS-986393 is safe and works well.
If you're interested, talk to your doctor to see if you can participate and understand all risks and benefits. 😊
NCT06297226
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
11 July 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.